Macdent Pharmaceuticals Private Limited

Macdent Pharmaceuticals Private Limited - chemicals in Delhi, India. Directors, charges & compliance details.
CIN U24290DL2022PTC399744 Incorporated 09 June 2022 ROC Delhi HQ Delhi, India
Active Private Limited Company chemicals MSME · Micro
Data last updated
Revenue · FY 2025
₹20.95 Lakh
▲ 11% YoY
Net profit · FY 2025
₹21,523
Net margin 1%
EBITDA · FY 2025
₹26,851
EBITDA margin 1.3%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
4
As per MCA filings
Last financials
Mar 2025
Balance sheet date

About Macdent Pharmaceuticals Private Limited

Data last updated:

Macdent Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 09 June 2022.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290DL2022PTC399744.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Vijay Kumar Chaturvedi and Amit Jaiswal.

Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 2/205 G/F Main 28Ft Road Rect No – 28 Kill No – 10 West Karawal Nagar, Delhi, India – 110094.

As per the financials filed for FY 2025, the company reported a revenue of ₹20.95 Lakh, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹21,523 (net margin 1%) and EBITDA of ₹26,851 (EBITDA margin 1.3%).

Macdent Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-11-0038362).

Company Details of Macdent Pharmaceuticals Private Limited
CIN U24290DL2022PTC399744
Registration Number 399744
Incorporation Date 09 June 2022
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 25 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-DL-11-0038362

Recognitions & Rankings of Macdent Pharmaceuticals

MSME (Udyam registered) Ministry of MSME
Category
Micro (2022-23)
Udyam number
UDYAM-DL-11-0038362
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    C – 2/205 G/F Main 28Ft Road Rect No – 28 Kill No – 10 West Karawal Nagar, Delhi, India – 110094
  • Industry
    Chemicals, Manufacturing, Other Chemical Product
Comprehensive company report
Macdent Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Macdent Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Macdent Pharmaceuticals Private Limited in one report.

Financials from FY 2023 Directors & ownership Charges & compliance

Business Activity of Macdent Pharmaceuticals Private Limited

The main business activity of Macdent Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.

Main Activity Group CodeDescription of Main ActivityBusiness Activity CodeDescription of Business ActivityTurnover Percentage
QHospital and Medical CareQ6Other Hospital and Medical Care ActivitiesLocked
Premium access

Business activity turnover details

Turnover share and past changes in activity are in the company report.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Financials of Macdent Pharmaceuticals Private Limited FY 2025 filings available

Macdent Pharmaceuticals Private Limited reported revenue of ₹20.95 Lakh (up 11% YoY) for FY 2025.

Revenue · FY 2025
₹20.95 Lakh ▲ 11%
Net profit · FY 2025
₹21,523 margin 1%
EBITDA · FY 2025
₹26,851 margin 1.3%

Compounded Annual Growth Rate (CAGR) of Macdent Pharmaceuticals Private Limited

Revenue CAGR growth
1 year
▲ 11%
EBITDA CAGR growth
1 year
▲ 65%

Revenue rose 11% in the latest year. EBITDA rose 65% in the latest year. All are worked out from the filed statements.

Financial Statement Summary of Macdent Pharmaceuticals Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23
Profit and Loss Statement
Revenue from Operations••••••••••••
Other Income••••••••••••
Total Revenue••••••••••••
Cost of Materials Consumed••••••••••••
Employee Benefit Expense••••••••••••
Finance Costs••••••••••••
Depreciation and Amortisation••••••••••••
Other Expenses••••••••••••
Total Expenses••••••••••••
EBITDA₹26,851••••••••
Profit Before Tax••••••••••••
Tax Expense••••••••••••
Net Profit (PAT)₹21,523••••••••
Balance Sheet
Share Capital••••••••••••
Reserves and Surplus••••••••••••
Net Worth (Total Equity)••••••••••••
Long-term Borrowings••••••••••••
Short-term Borrowings••••••••••••
Trade Payables••••••••••••
Total Liabilities••••••••••••
Fixed Assets••••••••••••
Investments••••••••••••
Inventories••••••••••••
Trade Receivables••••••••••••
Cash and Bank Balance••••••••••••
Total Assets••••••••••••

Financial Ratios of Macdent Pharmaceuticals Private Limited

MetricsFY 2024-25FY 2023-24FY 2022-23
Profitability
EBITDA Margin1.3%••••••••
Net Profit Margin1%••••••••
Return on Equity (ROE)••••••••••••
Return on Capital Employed (ROCE)••••••••••••
Return on Assets (ROA)••••••••••••
Liquidity and Debt
Current Ratio••••••••••••
Quick Ratio••••••••••••
Debt-to-Equity Ratio••••••••••••
Interest Coverage Ratio••••••••••••
Efficiency and Growth
Asset Turnover••••••••••••
Receivable Days••••••••••••
Payable Days••••••••••••
Inventory Days••••••••••••
Revenue Growth••••••••••••
Net Profit Growth••••••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Macdent Pharmaceuticals are in the company report.

Premium access

Financial statements from FY 2023

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Macdent Pharmaceuticals Private Limited

Macdent Pharmaceuticals has 4 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Vijay Kumar ChaturvediDirector09 Jun 20224 Years 4 MonthsCurrent
Amit JaiswalDirector09 Jun 20224 Years 4 MonthsCurrent
Arvind VishwakarmaDirector09 Jun 20224 Years 4 MonthsCurrent
Gautam MauryaDirector11 Jul 20224 Years 3 MonthsCurrent

Peer Comparison of Macdent Pharmaceuticals Private Limited

Macdent Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Lloyo Pharmaceuticals Private Limited₹21.2 Lakh (FY 2024)••••••••17.0%••••Pune, Maharashtra, India
Tristar Pharmaceuticals Private Limited₹21.18 Lakh (FY 2025)••••••••9.0%••••Chandigarh, India
GSV Pharmaceuticals Private Limited₹21.17 Lakh (FY 2024)••••••••7.0%••••Gurugram, Haryana, India
Arch Pharmaceuticals Private Limited₹21.12 Lakh (FY 2022)••••••••36.0%••••Gopalganj, Bihar, India
GHC Drugs and Pharmaceuticals Private Limited₹21.03 Lakh (FY 2024)••••••••8.0%••••Mumbai, Maharashtra, India
Macdent Pharmaceuticals Private Limited this company₹20.95 Lakh (FY 2025)••••••••11.0%••••Delhi, India
Zibran Pharmaceuticals Private Limited₹20.93 Lakh (FY 2024)••••••••-76.0%••••Godhra, Gujarat, India
Nionex Pharmaceuticals (OPC) Private Limited₹20.91 Lakh (FY 2025)••••••••393.0%••••Chennai, Tamil Nadu, India
Kegel Pharmaceuticals Private Limited₹20.85 Lakh (FY 2025)••••••••••••Ranchi, Jharkhand, India
Cantus Pharmaceuticals Private Limited₹20.81 Lakh (FY 2025)••••••••-7.0%••••Hyderabad, Telangana, India
Medzenexa Pharmaceuticals Private Limited₹20.8 Lakh (FY 2024)••••••••446.0%••••Varanasi, Uttar Pradesh, India

Peers are the five companies nearest above and the five nearest below Macdent Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Charges & Borrowings of Macdent Pharmaceuticals Private Limited

Macdent Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance at Macdent Pharmaceuticals Private Limited

Employment history and EPFO contributions of people linked to Macdent Pharmaceuticals.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Macdent Pharmaceuticals Private Limited

Macdent Pharmaceuticals Private Limited has 4 board changes on record since 2022: 4 appointments. The latest: Gautam Maurya was appointed as Director on 11 Jul 2022.

AGM
Macdent Pharmaceuticals Private Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records.
Filing
Macdent Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Gautam Maurya was appointed as Director.
Appointed
Amit Jaiswal was appointed as Director.
Appointed
Arvind Vishwakarma was appointed as Director.
Appointed
Vijay Kumar Chaturvedi was appointed as Director.
Incorporation
09 Jun 2022
Macdent Pharmaceuticals Private Limited was registered on 09 Jun 2022 with Roc Delhi & aged 4 years 4 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Macdent Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Macdent Pharmaceuticals Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Macdent Pharmaceuticals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Macdent Pharmaceuticals Private Limited

Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Macdent Pharmaceuticals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Macdent Pharmaceuticals Private Limited

Macdent Pharmaceuticals is an active private limited company based in Delhi, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 09 June 2022 (4+ years old) and is registered under CIN U24290DL2022PTC399744.

Macdent Pharmaceuticals reported revenue of ₹20.95 Lakh for FY 2025 (up 11% YoY).

Macdent Pharmaceuticals has 4 current directors:

Macdent Pharmaceuticals reported a net profit of ₹21,523 (net margin 1%) and EBITDA of ₹26,851 (EBITDA margin 1.3%) for FY 2025, as per its filed financial statements.

The CIN (Corporate Identification Number) of Macdent Pharmaceuticals is U24290DL2022PTC399744. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Macdent Pharmaceuticals was incorporated on 09 June 2022, making it 4+ years old. It is registered with the Registrar of Companies, Delhi.

The peers of Macdent Pharmaceuticals by revenue are Lloyo Pharmaceuticals Private Limited, Tristar Pharmaceuticals Private Limited, GSV Pharmaceuticals Private Limited, Arch Pharmaceuticals Private Limited, GHC Drugs and Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).

Gautam Maurya was appointed as Director on 11 Jul 2022. Amit Jaiswal was appointed as Director on 09 Jun 2022. Arvind Vishwakarma was appointed as Director on 09 Jun 2022. Macdent Pharmaceuticals has 4 board changes on record in total.

Yes, Macdent Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-11-0038362).

The registered office of Macdent Pharmaceuticals is at C – 2205 GF Main 28Ft Road Rect No – 28 Kill No – 10 West Karawal Nagar, Delhi, India – 110094.

Macdent Pharmaceuticals has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available